Lam Research (NASDAQ:LRCX) Price Target Raised to $175.00 at B. Riley

Key Points

• B. Riley has raised the price target for Lam Research (NASDAQ:LRCX) from $160.00 to $175.00, indicating a potential upside of 21.46% from its current price, alongside maintaining a "buy" rating.
• Several other analysts have also upgraded their price targets for Lam Research, with Deutsche Bank increasing it from $100.00 to $150.00, reflecting strong market confidence.
• Lam Research reported a quarterly revenue of $5.17 billion, surpassing expectations and showing a significant year-over-year growth of 33.6%.

Lam Research (NASDAQ:LRCX - Get Free Report) had its price target lifted by stock analysts at B. Riley from $160.00 to $175.00 in a note issued to investors on Monday,MarketScreener reports. The firm currently has a "buy" rating on the semiconductor company's stock. B. Riley's price objective would indicate a potential upside of 21.46% from the company's current price.

A number of other analysts have also recently commented on LRCX. Stifel Nicolaus set a $135.00 price target on shares of Lam Research and gave the company a "buy" rating in a research note on Monday, October 13th. Deutsche Bank Aktiengesellschaft upgraded Lam Research from a "hold" rating to a "buy" rating and increased their price target for the company from $100.00 to $150.00 in a research note on Monday, September 29th. Needham & Company LLC lifted their price objective on shares of Lam Research from $110.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. Raymond James Financial increased their target price on Lam Research from $90.00 to $110.00 and gave the stock an "outperform" rating in a research note on Thursday, July 31st. Finally, Rothschild & Co Redburn increased their price objective on Lam Research from $140.00 to $150.00 and gave the stock a "buy" rating in a research report on Tuesday, October 14th. Twenty-three research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, Lam Research currently has a consensus rating of "Moderate Buy" and an average target price of $128.04.

Lam Research Price Performance

Shares of LRCX stock opened at $144.09 on Monday. The firm's 50 day moving average is $119.06 and its 200-day moving average is $97.16. Lam Research has a 1 year low of $56.32 and a 1 year high of $153.70. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $181.70 billion, a price-to-earnings ratio of 34.66, a PEG ratio of 1.72 and a beta of 1.84.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, topping analysts' consensus estimates of $1.21 by $0.12. The company had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The business's quarterly revenue was up 33.6% compared to the same quarter last year. During the same period last year, the firm posted $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Sell-side analysts forecast that Lam Research will post 3.71 EPS for the current fiscal year.

Insider Buying and Selling

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company's stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the sale, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.31% of the company's stock.

Institutional Trading of Lam Research

Several institutional investors have recently added to or reduced their stakes in LRCX. Smallwood Wealth Investment Management LLC bought a new stake in shares of Lam Research in the 1st quarter valued at $26,000. IMG Wealth Management Inc. acquired a new position in Lam Research in the second quarter valued at $26,000. Howard Hughes Medical Institute bought a new stake in Lam Research during the second quarter valued at $27,000. Strategic Wealth Investment Group LLC acquired a new stake in Lam Research during the 2nd quarter worth about $29,000. Finally, Delos Wealth Advisors LLC bought a new position in shares of Lam Research in the 2nd quarter worth about $30,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.